Tick salivary sialostatin L represses the initiation of immune responses by targeting IRF4-dependent transcription in murine mast cells

Journal of Immunology

Volumn 195, Issue 2, 2015, Pages 621-631

  Klein, Matthias ^a   Bruhl, Till Julius ^a   Staud, Valérie ^a   Reuter, Sebastian ^a   Grebe, Nadine ^a   Gerlitzki, Bastian ^a   Hoffmann, Markus ^a   Bohn, Toszka ^a   Ulges, Alexander ^a   Stergiou, Natascha ^a   De Graaf, Jos ^a   Lower, Martin ^a   Taube, Christian ^b   Becker, Marc ^a   Hain, Tobias ^a   Dietzen, Sarah ^a   Stassen, Michael ^a   Huber, Magdalena ^c   Lohoff, Michael ^c   Chagas, Andrezza Campos ^d   Andersen, John ^d   Kota, Jan ^e   Langhansova, Helena ^e,f   Kopecky, Jan ^e,f   Schild, Hansjo I ^a   Kotsyfakis, Michalis ^e   Schmitt, Edgar ^a   Bopp, Tobias ^a   more..

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Inst f Med Mikrobiologie und Krankenhaushygiene   (Germany)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^e INSTITUTE OF PARASITOLOGY   (Czech Republic)

^f UNIVERSITY OF SOUTH BOHEMIA   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTATIN; INTERFERON REGULATORY FACTOR 4; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 9; SIALOSTATIN L; UNCLASSIFIED DRUG; IMMUNOSUPPRESSIVE AGENT; INTERFERON REGULATORY FACTOR; INTERFERON REGULATORY FACTOR-4; PROTEIN BINDING; SIALOSTATIN L, IXODES SCAPULARIS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG POTENCY; EXPERIMENTAL ASTHMA; FEMALE; GENE CONTROL; GENE LOCUS; IL1B GENE; IL9 GENE; IMMUNOREGULATION; MALE; MAST CELL; MAST CELL DEGRANULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; ASTHMA; BAGG ALBINO MOUSE; BINDING SITE; C57BL MOUSE; DEFICIENCY; DEGRANULATION; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HOST PARASITE INTERACTION; IMMUNOLOGY; INNATE IMMUNITY; KNOCKOUT MOUSE; PATHOLOGY;

ANIMALS; ASTHMA; BINDING SITES; CELL DEGRANULATION; CYSTATINS; GENE EXPRESSION REGULATION; HOST-PARASITE INTERACTIONS; IMMUNITY, INNATE; IMMUNOSUPPRESSIVE AGENTS; INTERFERON REGULATORY FACTORS; INTERLEUKIN-1BETA; INTERLEUKIN-6; INTERLEUKIN-9; MAST CELLS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RECEPTORS, INTERLEUKIN-1; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 84936802171     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1401823     Document Type: Article

References (39)

1. Kazimírova, M., and I. Stibraniova. 2013. Tick salivary compounds: their role in modulation of host defences and pathogen transmission. Front. Cell. Infect. Microbiol. 3: 43.
2. Kotsyfakis, M., A. Sa-Nunes, I. M. Francischetti, T. N. Mather, J. F. Andersen, and J. M. Ribeiro. 2006. Antiinflammatory and immunosuppressive activity of sialostatin L, a salivary cystatin from the tick Ixodes scapularis. J. Biol. Chem. 281: 26298-26307.
3. Sa-Nunes, A, A. Bafica, L. R. Antonelli, E. Y. Choi, I. M. Francischetti, J. F Andersen, G. P. Shi, T. Chavakis, J. M. Ribeiro, and M. Kotsyfakis. 2009. The immunomodulatory action of sialostatin L on dendritic cells reveals its potential to interfere with autoimmunity. J. Immunol. 182: 7422-7429.
4. Horka, H., V. Staudt, M. Klein, C. Taube, S. Reuter, N. Dehzad, J. F Andersen, J. Kopecky, H. Schild, M. Kotsyfakis, et al. 2012. The tick salivary protein sialostatin L inhibits the Th9-derived production of the asthma-promoting cytokine IL-9 and is effective in the prevention of experimental asthma. J. Immunol. 188: 2669-2676.
5. Stassen, M., E. Schmitt, and T Bopp. 2012. From interleukin-9 to T helper 9 cells. Ann. N. Y. Acad. Sci. 1247: 56-68.
6. Marshall, J. S. 2004. Mast-cell responses to pathogens. Nat. Rev. Immunol. 4: 787-799.
7. Matsushima, H., N. Yamada, H. Matsue, and S. Shimada. 2004. TLR3-, TLR7-, and TLR9-mediated production of proinflammatory cytokines and chemokines from murine connective tissue type skin-derived mast cells but not from bone marrow-derived mast cells. J. Immunol. 173: 531-541.
8. Galli, S. J., J. Kalesnikoff, M. A. Grimbaldeston, A. M. Piliponsky, C. M. Williams, and M. Tsai. 2005. Mast cells as "tunable" effector and im-munoregulatory cells: recent advances. Annu. Rev. Immunol. 23: 749-786.
9. Hultner, L., S. Kolsch, M. Stassen, U. Kaspers, J. P. Kremer, R. Mailhammer, J. Moeller, H. Broszeit, and E. Schmitt. 2000. In activated mast cells, IL-1 up-regulates the production of several Th2-related cytokines including IL-9. J. Immunol. 164: 5556-5563.
10. Stassen, M., M. Arnold, L. Hultner, C. Muller, C. Neudorfl, T. Reineke, and E. Schmitt. 2000. Murine bone marrow-derived mast cells as potent producers of IL-9: costimulatory function of IL-10 and kit ligand in the presence of IL1. J. Immunol. 164: 5549-5555.
11. Stassen, M., C. Muller, M. Arnold, L. Hultner, S. Klein-Hessling, C. Neudorfl, T. Reineke, E. Serfling, and E. Schmitt. 2001. IL-9 and IL-13 production by activated mast cells is strongly enhanced in the presence of lipopolysaccharide: NF-kappa B is decisively involved in the expression of IL-9. J. Immunol. 166: 4391-4398.
12. Stassen, M., M. Klein, M. Becker, T. Bopp, C. Neudörfl, C. Richter, V. Heib, S. Klein-Hessling, E. Serfling, H. Schild, and E. Schmitt. 2007. p38 MAP kinase drives the expression of mast cell-derived IL-9 via activation of the transcription factor GATA-1. Mol. Immunol. 44: 926-933.
13. Mittrücker, H. W., T. Matsuyama, A. Grossman, T. M. Kündig, J. Potter, A. Shahinian, A. Wakeham, B. Patterson, P. S. Ohashi, and T. W. Mak. 1997. Requirement for the transcription factor LSIRF/IRF4 for mature B and T lymphocyte function. Science 275: 540-543.
14. Glaccum, M. B., K. L. Stocking, K. Charrier, J. L. Smith, C. R. Willis, C. Maliszewski, D. J. Livingston, J. J. Peschon, and P. J. Morrissey. 1997. Phenotypic and functional characterization of mice that lack the type I receptor for IL-1. J. Immunol. 159: 3364-3371.
15. Horai, R., M. Asano, K. Sudo, H. Kanuka, M. Suzuki, M. Nishihara, M. Takahashi, and Y. Iwakura. 1998. Production of mice deficient in genes for interleukin (IL)-1alpha, IL-1beta, IL-1alpha/beta, and IL-1 receptor antagonist shows that IL-1beta is crucial in turpentine-induced fever development and glucocorticoid secretion. J. Exp. Med. 187: 1463-1475.
16. Geissler, E. N., E. C. McFarland, and E. S. Russell. 1981. Analysis of pleio-tropism at the dominant white-spotting (W) locus of the house mouse: A description of ten new W alleles. Genetics 97: 337-361.
17. Tharp, M. D., L. L. Seelig, Jr., R. E. Tigelaar, and P. R. Bergstresser. 1985. Conjugated avidin binds to mast cell granules. J. Histochem. Cytochem. 33: 27-32.
18. Schmitt, E., R. Van Brandwijk, J. Van Snick, B. Siebold, and E. Rüde. 1989. TCGF III/P40 is produced by naive murine CD4+ T cells but is not a general T cell growth factor. Eur. J. Immunol. 19: 2167-2170.
19. Langmead, B., C. Trapnell, M. Pop, and S. L. Salzberg. 2009. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 10: R25.
20. Pruitt, K. D., T. Tatusova, and D. R. Maglott. 2005. NCBI Reference Sequence (RefSeq): A curated non-redundant sequence database of genomes, transcripts and proteins. Nucleic Acids Res. 33: D501-D504.
21. Mortazavi, A., B. A. Williams, K. McCue, L. Schaeffer, and B. Wold. 2008. Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat. Methods 5: 621-628.
22. Staudt, V., E. Bothur, M. Klein, K. Lingnau, S. Reuter, N. Grebe, B. Gerlitzki, M. Hoffmann, A. Ulges, C. Taube, et al. 2010. Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells. Immunity 33: 192-202.
23. Liang, M. D., Y. Zhang, D. McDevit, S. Marecki, and B. S. Nikolajczyk. 2006. The interleukin-1beta gene is transcribed from a poised promoter architecture in monocytes. J. Biol. Chem. 281: 9227-9237.
24. Zhang, Y., S. Saccani, H. Shin, and B. S. Nikolajczyk. 2008. Dynamic protein associations define two phases of IL-1beta transcriptional activation. J. Immunol. 181: 503-512.
25. Nakae, S., L. H. Ho, M. Yu, R. Monteforte, M. Iikura, H. Suto, and S. J. Galli. 2007. Mast cell-derived TNF contributes to airway hyperreactivity, inflammation, and TH2 cytokine production in an asthma model in mice. J. Allergy Clin. Immunol. 120: 48-55.
26. Williams, C. M., and S. J. Galli. 2000. Mast cells can amplify airway reactivity and features of chronic inflammation in an asthma model in mice. J. Exp. Med. 192: 455-462.
27. Louahed, J., Y. Zhou, W. L. Maloy, P. U. Rani, C. Weiss, Y. Tomer, A. Vink, J. Renauld, J. Van Snick, N. C. Nicolaides, et al. 2001. Interleukin 9 promotes influx and local maturation of eosinophils. Blood 97: 1035-1042.
28. Stibrániová, I., M. Lahová, and P. Bartíková. 2013. Immunomodulators in tick saliva and their benefits. Acta Virol. 57: 200-216.
29. Rüter, C., and P. R. Hardwidge. 2014. 'Drugs from bugs': bacterial effector proteins as promising biological (immune-) therapeutics. FEMS Microbiol. Lett. 351: 126-132.
30. Schmitt, E., T. Germann, S. Goedert, P. Hoehn, C. Huels, S. Koelsch, R. Kühn, W. M üller, N. Palm, and E. Rüde. 1994. IL-9 production of naive CD4+ T cells depends on IL-2, is synergistically enhanced by a combination of TGF-beta and IL-4, and is inhibited by IFN-gamma. J. Immunol. 153: 3989-3996.
31. Temann, U. A., G. P. Geba, J. A. Rankin, and R. A. Flavell. 1998. Expression of interleukin 9 in the lungs of transgenic mice causes airway inflammation, mast cell hyperplasia, and bronchial hyperresponsiveness. J. Exp. Med. 188: 1307-1320.
32. Wiener, Z., A. Falus, and S. Toth. 2004. IL-9 increases the expression of several cytokines in activated mast cells, while the IL-9-induced IL-9 production is inhibited in mast cells of histamine-free transgenic mice. Cytokine 26: 122-130.
33. Chang, H.-C., S. Sehra, R. Goswami, W. Yao, Q. Yu, G. L. Stritesky, R. Jabeen, C. McKinley, A.-N. Ahyi, L. Han, et al. 2010. The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammation. Nat. Immunol. 11: 527-534.
34. Zhang, P., X. Zhang, A. Iwama, C. Yu, K. A. Smith, B. U. Mueller, S. Narravula, B. E. Torbett, S. H. Orkin, and D. G. Tenen. 2000. PU.1 inhibits GATA-1 function and erythroid differentiation by blocking GATA-1 DNA binding. Blood 96: 2641-2648.
35. Ranganath, S., and K. M. Murphy. 2001. Structure and specificity of GATA proteins in Th2 development. Mol. Cell. Biol. 21: 2716-2725.
36. Purwar, R., C. Schlapbach, S. Xiao, H. S. Kang, W. Elyaman, X. Jiang, A. M. Jetten, S. J. Khoury, R. C. Fuhlbrigge, V. K. Kuchroo, et al. 2012. Robust tumor immunity to melanoma mediated by interleukin-9-producing T cells. Nat. Med. 18: 1248-1253.
37. Kearley, J., J. S. Erjefalt, C. Andersson, E. Benjamin, C. P. Jones, A. Robichaud, S. Pegorier, Y. Brewah, T. J. Burwell, L. Bjermer, et al. 2011. IL-9 governs allergen-induced mast cell numbers in the lung and chronic remodeling of the airways. Am. J. Respir. Crit. Care Med. 183: 865-875.
38. Oh, C. K., D. Raible, G. P. Geba, and N. A. Molfino. 2011. Biology of the interleukin-9 pathway and its therapeutic potential for the treatment of asthma. Inflamm. Allergy Drug Targets 10: 180-186.
39. Oh, C. K., R. Leigh, K. K. McLaurin, K. Kim, M. Hultquist, and N. A. Molfino. 2013. A randomized, controlled trial to evaluate the effect of an anti-interleukin-9 monoclonal antibody in adults with uncontrolled asthma. Respir. Res. 14: 93.